Recruiting Clinical Trials

Displaying 71 - 80 of 245 result(s)
Study Title Condition Phase Location
A Randomized, Participant- and Investigator-blinded, Placebo-controlled Study to Investigate Efficacy, Safety, and Tolerability of LTP001 in Participants With Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension Phase 2
  • Country: 
    Germany
  • Country: 
    Poland
An Open-label, Multi-center Rollover Protocol for Patients Who Have Participated in a Novartis-sponsored Ribociclib (LEE011) Study and Are Continuing to Benefit From Ribociclib as Single Agent or in Combination With Other Investigational Treatments Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies Phase 2
  • Country: 
    Singapore
  • Country: 
    Taiwan
A Two-part, Randomized, Investigator- and Participant- Blinded, Placebo-controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MHS552 in Adult Participants With Systemic Lupus Erythemato ... Lupus Erythematosus, Systemic Phase 1
  • Country: 
    Germany
A Randomized, Four-arm, Canakinumab Placebo-controlled, Participant, Investigator and Sponsor-blinded Study Investigating the Safety, Tolerability and Efficacy of Intra-articular Canakinumab Followed by Intra-articular LNA043 in Patients With Knee Os ... Knee Osteoarthritis Phase 2
  • Country: 
    United States
  • Country: 
    China
  • Country: 
    Czech Republic
  • Country: 
An Open-label, Phase I, Dose Escalation, Expansion Study of MGY825 in Adult Patients With Advanced Non-small Cell Lung Cancer Non-small Cell Lung Cancer Phase 1
  • Country: 
    Germany
  • Country: 
    Japan
  • Country: 
    Spain
Multicenter, Open-label, Single-arm Study to Evaluate the PK, Safety, Tolerability and Efficacy of a New Artemether:Lumefantrine (2.5 mg:30 mg) Dispersible Tablet in the Treatment of Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Pla ... Plasmodium Falciparum Malaria Phase 2, Phase 3
  • Country: 
    Burkina Faso
  • Country: 
    Congo, The Democratic Republic of the
  • Country: 
    Mali
  • Country: 
A Randomized, Participant- and Investigator-blinded, Placebo-controlled, Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants Healthy Volunteers Phase 1
  • Country: 
    United Kingdom
A Randomized, Subject- and Investigator-blinded, Placebo-controlled, Parallel Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Patients With Bronchiectasis Bronchiectasis Phase 2
  • Country: 
    China
  • Country: 
    Germany
  • Country: 
    Spain
  • Country: 
An Open-label, Multi-center, Phase I, Dose Finding Study of Oral TNO155 in Adult Patients With Advanced Solid Tumors Advanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,Melanoma Phase 1
  • Country: 
    United States
  • Country: 
    Canada
  • Country: 
    Japan
  • Country: 
Phase II/III Study for Evaluation of the Diagnostic Performance of [18F]CTT1057 PET Imaging for the Detection of PSMA Positive Tumors Using Histopathology as a Standard of Truth Prostatic Neoplasms, Prostate Cancer Phase 2, Phase 3
  • Country: 
    France
  • Country: 
    Italy
  • Country: 
    Spain
  • Country: